Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CBL-0137 by Incuron for Lymphoma: Likelihood of Approval
CBL-0137 is under clinical development by Incuron and currently in Phase II for Lymphoma. According to GlobalData, Phase II drugs...
Data Insights
CBL-0137 by Incuron for Central Nervous System (CNS) Tumor: Likelihood of Approval
CBL-0137 is under clinical development by Incuron and currently in Phase II for Central Nervous System (CNS) Tumor. According to...